December 3, 2025 · Form 4 insider transaction
O'Neill Gilmore Neil sold 5,603 shares of Editas Medicine, Inc. at $2.15 per share, a transaction worth $12.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 2, 2025. The sale does not represent a discretionary trade by the Reporting Person.